LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
VSXY
Victoria's Secret & Company
VSXY has the edge over LCID overall, supported by stronger fundamentals and stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
VSXY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
VSXY's revenue, profitability, cash flow and balance sheet are all currently healthy.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
VSXY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $30.32 | -71% |
| Fair | 14x | $60.95 | -42% |
| Forward | 20x | $105 | — |
| Current | 23x | $105 | — |
| Expensive | 24x | $108 | +3.3% |
Historical ranges are pointers, not guarantees.
VSXY's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 20x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
VSXY Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for VSXY, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
VSXY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.24 | +17% |
| Q3 2026 | $4.49 | +139% |
| Q2 2026 | $2.51 | +21% |
| Q1 2026 | $1.93 | -5.9% |
| Q4 2025 | $2.13 | +8.7% |
| Q3 2025 | $1.88 | +7.4% |
| Q2 2025 | $2.08 | +56% |
| Q1 2025 | $2.05 | +47% |
| Q4 2024 | $1.96 | +69% |
VSXY has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over VSXY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
VSXY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +10% |
| Q2 2026 | $1.6B | +15% |
| Q1 2026 | $2.3B | +7.7% |
| Q4 2025 | $1.5B | +9.3% |
| Q3 2025 | $1.5B | +3% |
| Q2 2025 | $1.4B | -0.4% |
| Q1 2025 | $2.1B | +1.1% |
| Q4 2024 | $1.3B | +6.5% |
VSXY's revenue has grown year over year for five quarters in a row: $1.6B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +13 points |
| Q2 2026 | 4.9% | +3.4 points |
| Q1 2026 | 10% | -2.6 points |
| Q4 2025 | -1.3% | +2.2 points |
| Q3 2025 | 2.8% | -1.6 points |
| Q2 2025 | 1.5% | -0.4 points |
| Q1 2025 | 13% | +0.3 points |
| Q4 2024 | -3.5% | +1.8 points |
VSXY has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
VSXY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $328M | +273% |
| Q2 2026 | -$191M | +$2M |
| Q1 2026 | $649M | +0.5% |
| Q4 2025 | -$232M | +$67M |
| Q3 2025 | $88M | +60% |
| Q2 2025 | -$193M | -$38M |
| Q1 2025 | $646M | +16% |
| Q4 2024 | -$299M | -$38M |
VSXY has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VSXY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 2.2x | Moderate |
VSXY's net debt is less than a year of its operating earnings (EBITDA), down from 1.6 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
VSXY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.4 | Neutral |
| Stochastic | 83.0 | Overbought |
VSXY's weekly RSI is 65 (neutral) and its Stochastic is 83 (overbought).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
VSXY PE vs Consumer Cyclical Sector
| Metric | VSXY | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 29% above |
| PE % | 82 | 55 | 27 pts above |
VSXY is trading at 23x earnings, a 29% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
VSXY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $93.1 | 12% above |
| 20 week MA | $87.2 | 20% above |
| 50 week MA | $69.2 | 51% above |
| 100 week MA | $47.9 | 119% above |
| 200 week MA | $36.4 | 188% above |
VSXY has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
VSXY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $42.1 | $49.1 | +17% |
| 2022 | $49.1 | $40.4 | -18% |
| 2023 | $40.4 | $26.5 | -34% |
| 2024 | $26.5 | $42.3 | +59% |
| 2025 | $42.3 | $53.8 | +27% |
| 2026 YTD | $53.8 | $104.6 | +94% |
VSXY has the edge over LCID on returns for 2026, with the stronger performance.